TPST CIK: 1544227

Tempest Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.0
FY22:
−31.1
FY23:
−27.4
FY24:
−33.0
FY25:
−26.8
Change from FY21 to FY25
millions USD
FY21:
−0.10
FY22:
−0.56
FY23:
−0.17
FY24:
−0.44
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
59.1
FY22:
11.4
FY23:
35.6
FY24:
24.5
FY25:
4.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.1
FY22:
−31.6
FY23:
−27.5
FY24:
−33.5
FY25:
−26.8

All amounts in millions USD Data source:SEC EDGAR